tiprankstipranks
Advertisement
Advertisement
NextCure expects SIM0505 Phase 1 dose escalation data update in Q2
PremiumThe FlyNextCure expects SIM0505 Phase 1 dose escalation data update in Q2
3M ago
Two new option listings and eighteen option delistings on December 22nd
Premium
The Fly
Two new option listings and eighteen option delistings on December 22nd
5M ago
NextCure Launches At-The-Market Stock Offering Program
Premium
Company Announcements
NextCure Launches At-The-Market Stock Offering Program
5M ago
NextCure prices 2.5M shares at $8.52 in private placement
PremiumThe FlyNextCure prices 2.5M shares at $8.52 in private placement
6M ago
NextCure upgraded to Buy from Neutral at Ladenburg
Premium
The Fly
NextCure upgraded to Buy from Neutral at Ladenburg
6M ago
NextCure Advances Cancer Therapies Amid Financial Adjustments
Premium
Company Announcements
NextCure Advances Cancer Therapies Amid Financial Adjustments
6M ago
NextCure’s Chief Scientific Officer Resigns
PremiumCompany AnnouncementsNextCure’s Chief Scientific Officer Resigns
8M ago
NextCure Reports Q2 2025 Results and Strategic Updates
Premium
Company Announcements
NextCure Reports Q2 2025 Results and Strategic Updates
9M ago
Closing Bell Movers: Intel slides after quarterly report
Premium
The Fly
Closing Bell Movers: Intel slides after quarterly report
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100